Why metabolic health matters more than weight loss

Ozempic and Wegovy have brought GLP-1 drugs into mainstream discussion, but the article argues the next shift should focus on metabolic health rather than the scale alone. A KFF Health Tracking Poll in November 2025 found about 1 in 8 U.S. adults has taken a GLP-1 medication, fueling attention on weight loss. Physicians and researchers say visible changes can mask what is happening inside, since metabolic health depends on multiple markers including blood sugar, insulin sensitivity, cholesterol, and blood pressure. The American Heart Association estimates about 90% of U.S. adults fall within a cardiovascular-kidney-metabolic health spectrum. The piece notes BMI cannot distinguish fat from muscle or show fat distribution, and emphasizes that metabolic health cannot be captured by a single test. It points to habit-based approaches and monitoring key indicators with healthcare professionals.